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Abstract
Introduction—Nemaline myopathy (NEM) is one of the most common congenital myopathies.
A unique subtype, NEM6, maps to chromosome 15q21-q23 in two pedigrees, but the causative
gene has not been determined.
Methods—We conducted clinical examination and myopathological studies in a new NEM
family. Genotyping and gene screening were accomplished by searching known and 18 new
candidate genes.
Results—The disease started in childhood by affecting proximal and distal muscles and causing
slowness of movements. Muscle biopsies show numerous nemaline rods and core-like formations.
Suggestive linkage to chromosome 15q22-q23 was established. Genes known to be mutated in
NEM or core-rod myopathy were screened and excluded. No pathogenic mutations were identified
in other candidate genes.
Discussion—The disease in this Spanish family is classified as NEM6. It is phenotypically
similar and probably allelic to the two previously reported NEM6 pedigrees. Further studies of
these families will lead to the identification of the NEM6 gene.
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Introduction
Nemaline myopathy (NEM) is a congenital myopathy that is characterized clinically by
proximal muscle weakness and hypotonia and defined morphologically by eosinophilic rod-
shaped inclusions or nemaline bodies in muscle fibers 1–4. Several clinical types of NEM
are recognized based on the age of disease onset and severity of muscle weakness, ranging
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from a severe neonatal often lethal subtype to milder non-progressive or slowly progressive
forms that present in infancy, childhood or adulthood 5–7. Muscle weakness may be diffuse,
but it is often most pronounced in the face, neck and proximal limb muscles. Pharyngeal and
respiratory muscles are frequently affected 5. Distal weakness appears late in the course of
illness, but in some forms manifests at presentation 8. The pattern of inheritance is also
variable; autosomal recessive, autosomal dominant, and sporadic cases have been reported
8–11. Nemaline bodies are rod-shaped structures continuous with and derived from the Z-
disks 12. α-actinin is the major component of a nemaline rod 13,14. Other Z-disc proteins
including myotilin and nebulin are also expressed in rods 15,16. Type I fiber predominance
and atrophy or hypertrophy are other common features of nemaline myopathy 5,12,17.
Mutations that cause nemaline myopathy have been identified in α-actin (ACTA1), α-and β-
tropomyosin (TPM3 and TPM2), troponin T (TNNT1), nebulin (NEB), and cofilin2 (CFL2)
18. Mutations in the ryanodine receptor (RYR1) 19,20 and nebulin (NEB) 21 have in some
cases been found to be responsible for congenital core-rod myopathy. Recently, autosomal
dominant nemaline myopathy in two families, Dutch 22 and Australian-Dutch 23, was
mapped to a locus on chromosome 15q21-q23 with a combined LOD score of 10.65 at
marker D15S993 23 and named NEM6 (MIM 609273). Affected individuals in both reported
families developed the disease in their infancy or childhood and experienced very slowly
progressing weakness in the neck and proximal limb muscles with no facial, respiratory or
distal muscle involvement. Each patient of the Dutch family manifested slowness of
movements. Analysis of muscle biopsies in both families showed numerous rods and core-
like structures 22,23.
We describe clinical, myopathological and genetic findings in a Spanish family with four
cases fully consistent with published diagnostic criteria for nemaline myopathy 5,7. The
disease in this family maps to the 15q22.31 chromosomal locus fully congruent with the
region previously identified in the larger Dutch and Australian-Dutch families.
MATERIALS AND METHODS
The Spanish family
Four patients with myopathy have been identified in a family that originated from Andalucia
in Southern Spain (Figure 1). All affected and 7 unaffected family members underwent a
clinical study that included general neurologic exam, muscle strength assessment according
to the Medical Research Council (MRC) grading scale, serum CK test, and, if affected,
nerve conduction testing and concentric needle EMG. Respiratory function tests and
cardiological examination including ECG, 24-hour-Holter monitoring, and
echocardiography were performed in individuals II:3 and II:5.
Muscle imaging
Muscle imaging studies were carried out in individuals II:3, II:5 and III:5 at the age of 60,
55 and 34 years, respectively. In patient II:3, transverse and coronal T1-weighted spin-echo
(SE) and short-time inversion recovery (STIR) magnetic resonance imaging were performed
on 1.5-T MR (Intera Philips, Amsterdam, The Netherlands). In patients II:5 and III:5,
muscle imaging was performed using a helical CT scanner (HiSpeed NX/wiPRO, GE
Medical Systems, Milwaukee, WI).
Myopathological Studies
Two patients (II:3 and II:5) underwent muscle biopsy at the age of 49 and 50 years. No
muscle biopsies were performed during childhood. Samples obtained from the biceps brachii
muscle were frozen in liquid nitrogen-cooled isopentane and processed for routine
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histochemical reactions. Samples from patient II:5 were additionally processed for double
labeling of myosin isoforms and desmin immunohistochemistry using antibodies against
slow, fast, and developmental myosin (Novocastra, Newcastle upon Tyne, UK) at dilutions
1:100, 1:250, and 1:500, respectively, and desmin (Dako, Barcelona, Spain) at dilution 1:20.
Immunofluorescence analysis was carried out by using antibodies against α-actinin
(SIGMA, Saint Louis, Missouri, USA), myotilin (Novocastra, Newcastle upon Tyne, UK),
and filamin C (mouse monoclonal anti-filamin C antibody RR90 kindly provided by DO
Fürst) at dilutions 1:800, 1:200 and 1:25, respectively. The secondary antibody was Alexa
488 anti-mouse (Molecular Probes, Leyden, The Netherlands) used at dilution 1:400.
Sections were mounted with Fluorescent Mounting Medium (DakoCytomation, Glostrup,
Denmark), sealed and dried overnight at 4oC. A small piece of the muscle sample was
processed for ultrastructural examination using standard methods.
Screening for Known Nemaline Myopathy Genes
Genomic DNA of patients II:3 and II:5 was tested for the presence of mutations in the
coding regions of genes known or suspected to cause autosomal dominant nemaline
myopathy: ACTA1, TPM3, TPM2, TNNT1, and CFL2. PCR amplification with intronic
primers constructed to amplify each exon was carried out, and the resulting DNA fragments
were sequenced using BigDyeTerminator™ protocol on an automated 3100 ABI Prism
Genetic Analyzer (Applied Biosystems, Foster City, CA).
Genotyping
Genotyping of 11 members of the myopathy family was conducted with the use of markers
from 15q21-q23, the previously identified NEM6 chromosomal interval, and 19q12-q13.2,
the location of the candidate RYR1 gene. Haplotypes were determined using marker allele
segregation in the pedigree. LOD score for linkage was estimated by using the Fastlink
package.
Search for causative Genes in the Candidate Chromosomal Region
Genomic DNA of patients II:3 and II:5 was also tested for mutations in the following genes
positioned within the 15q21-q23 candidate region: ANXA, TPM1, Talin2, LACT, RABB,
HERC1, DAPK2, UPB3, PARP16, PPIB, MEMT, RASL12, CLPX, C15orf44, NOPE,
SCL24A1, RAB11A, and DIS3L. Techniques for PCR amplification and sequencing were the
same as described above. Validation of genomic DNA sequencing results was accomplished
by sequence analysis of complimentary DNA (cDNA) of ACTA1, TPM3, TPM2, TNNT1,
CFL2, TPM1, Talin2, and HERC1 transcripts, because they were considered supreme
candidates to be involved in this disease. Total RNA was extracted from skeletal muscle
biopsy tissue of patients II:3 and II:5 using the RNeasy Fibrous Tissue kit (Qiagen,
Valencia, CA). One microgram of total RNA was used for reverse transcription reaction
with MuLV Reverse Transcriptase (Applied Biosystems, Foster City, CA). Candidate
mutations were detected by aligning with appropriate database entries




Patients had a normal neonatal period and achieved normal motor milestones. They
presented around 4 or 5 years of age with muscle weakness in the arms and legs manifested
by gait abnormality and difficulties performing sports; they were unable to run or jump but
could walk long distances. Each patient complained of difficulties opening a jar and lifting
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heavy objects. The condition was very slowly progressive, with some acceleration in
adulthood. On examination, all studied patients had proximal and distal muscle weakness in
the upper and lower limbs. The deltoid and biceps muscles were weaker than the triceps
(MRC score 4/5); forearm flexors and extensors and hand muscles were equally affected
(MRC score 4/5). In the lower extremities, weakness was greatest in iliopsoas, hip
adductors, anterior tibialis, and the peroneal group. The quadriceps muscle was strong in all
affected individuals until late in the course of illness. Patients were unable to walk on heels
but could stand on their toes. None had facial weakness. In only two members (II:1 and III:
5, Figure 1), neck flexors and paraspinal muscles were also affected. Muscle hypotrophy
was present in the upper limbs, particularly in the forearm muscles (Figure 2). Slowness of
movements that transformed into bradykinetic slow-motion behavior and clumsiness was a
characteristic feature in each patient; patients were unable to sprint, had delayed startle
reflexes, and were unable to correct their position to avoid falls. Deep tendon reflexes were
preserved, except at the ankle; each patient had mild heel cord contracture. No cardiac or
respiratory symptoms were present, and no clinical or electrophysiological evidence of
peripheral neuropathy was detected. Three of 4 patients remained ambulant in their 30s to
60s. The oldest affected individual (II:2), now aged 74 years, is only able to walk short
distances with support. CK levels were normal, and EMGs showed a myopathic pattern.
Respiratory function tests and cardiological examination revealed no abnormalities.
Muscle MRI performed at the age of 60 years in individual II:3 showed diffuse involvement
of thigh muscles, slightly more pronounced in the adductor magnus. At mid leg level there
was a predominant involvement of the lateral and medial gastrocnemius, peroneal group and
soleus, with less prominent changes in the anterior tibialis muscle. An identical pattern of
muscle involvement was observed on a CT scan of his younger brother (II:5), but only
minimal abnormalities were seen in a younger patient III:5 (Figure 3).
Myopathology
Muscle biopsy of case II:3 revealed marked variation in fiber size and increased number of
internal nuclei (Figure 4A and B). There was mild endomysial fibrosis. A high proportion of
fibers contained aggregates of abnormal fine, granular, or rod-shaped structures in the
cytoplasm or in subsarcolemmal areas (Figure 4A and B); they were eosinophilic on HE
stain (Figure 4B and C) and dark blue to red-purple on the modified trichrome stain (Figure
4A). There were a few ragged red fibers, and occasional fibers contained rimmed vacuoles
(Figure 4C). In addition, some fibers harbored hyaline eosinophilic material beneath the
sarcolemma or centrally within the cytoplasm (Figure 4B). In the muscle biopsy of patient
II:5, typical nemaline rods were found in 90% of fibers (Figure 4D). They assembled into
clusters in the subsarcolemmal areas (Figure 4E) or as masses within the cytoplasm (Figure
4F and G); virtually all type I fibers were affected. On NADH and SDH reactions, both
patients showed fibers that contained core-like areas devoid of oxidative enzyme activity
and several ring fibers (Figure 4H and I). On ATPase staining, there was type I fiber
predominance and hypertrophy; most type II fibers were atrophic. Double labeling
immunohistochemistry for slow and fast myosin isoforms revealed marked predominance
and hypertrophy of type I (slow) fibers, and atrophy of type II (fast) fibers. A few atrophic
fibers co-expressed both slow and fast myosin (Figure 4J). No immature fibers were
observed. Rods and most of the core-like areas showed strong α-actinin, filamin C, and
myotilin immunofluorescence (Figure 5). Faint overexpression of desmin was seen in the
cytoplasm of several fibers. More enhanced desmin immunoreactivity was present under the
sarcolemma, or diffusely within the cytoplasm of atrophic fibers. However, fiber areas
corresponding to rods and core-like lesions displayed no desmin immunoreactivity (data not
shown).
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Electron-microscopic study uncovered numerous abnormal electron-dense structures
corresponding to rods; they protruded from the Z-lines and ran in a perpendicular direction
(Figure 6A and C). The sarcomere structure was preserved in some fibers (Figure 6C), but it
was severely disorganized in others (Figure 6A,E,F). On transverse sections collections of
small rods were observed (Figure 6D). The core-like areas seen on light microscopy
corresponded to regions where rods were abundant and the myofibrillar disruption was the
heaviest (Figure 6A,E,F). Some muscle fibers contained massive electrondense filamentous
material, probably of Z-disk origin but few rod-like structures (Figure 6E and F). Clusters of
mitochondria were seen at the periphery of the disorganized sarcomeres. The
myopathological diagnosis of nemaline myopathy was established based on the presence of
nemaline rods as the most relevant myopathologic feature (although additional core-like
lesions were present) and the absence of findings indicative of other disorders in which
nemaline bodies may also be present (for diagnostic criteria – see ref. 7).
Chromosomal assignment and candidate gene screening
Autosomal dominant inheritance is reliably confirmed in this Spanish family by the fact that
the disease was inherited from a man in his two consecutive marriages and the evidence of
male-to-male transmission (Figure 1). Screening of the coding exons of genes associated
with autosomal dominant NEM, ACTA1, TPM3, and TPM2 did not uncover meaningful
changes. In addition, CFL2 and TNNT1 (but not NEB) genes implicated so far in autosomal
recessive NEM, were also analyzed, and no mutations were found. Genotyping with
microsatellite markers in the 15q21-q23 region that contains the putative unknown NEM6
gene 23 resulted in the identification of a disease-associated 3-3-2-1-6 haplotype shared by
all affected but not the unaffected members of the family (Figure 1). The estimated LOD
score for linkage to the 15q21-q23 locus is 2.077. Suggestive linkage and the perfect
segregation of the disease-associated haplotype indicate that nemaline myopathy in this
family is linked to the same 15q21-q23 chromosomal region as in the Dutch and Australian-
Dutch families 23. Eighteen genes located in the candidate region segregating with the
disease, including ANXA, TPM1, Talin 2, LACT, RABB, HERC1, DAPK2, UPB3, PARP16,
PPIB, MEMT, RASL12, CLPX, C15orf44, NOPE, SCL24A1, RAB11A, and DIS3L were
screened, but the search failed to uncover a causative mutation. Genotyping in the RYR1
locus on chromosome 19q12-q13.2 excluded RYR1 gene involvement in this disease (not
shown).
DISCUSSION
Affected members of this nemaline myopathy family show phenotypic similarity with the
syndrome previously characterized in Dutch and Australian-Dutch families and should to be
designated NEM6 22,23. Shared clinical features include symmetric slowly progressive
proximal muscle weakness that starts around 4 or 5 years of age. These Spanish patients
show in addition distal muscle involvement, a feature that has not been observed in the
reported 15q-linked families, except for a single patient of the Australian-Dutch family who
showed weakness of ankle dorsiflexors 23. Most significantly, the affected members of the
Spanish family demonstrate slowness of movements that was previously described as a
characteristic feature of the 15q-linked nemaline myopathy families 23 “Slow walking” was
also mentioned in members of a family with nemaline myopathy due to mutations in the
TPM3 gene 24 and therefore is not unique to the 15q type of disease. Muscle imaging studies
were performed in three affected individuals. In the oldest patients diffuse involvement of
the thigh muscles was observed, similarly to what has been previously found in patients who
suffer from nemaline myopathy due to ACTA1 mutations. This is clearly different from the
selective involvement of the anterior compartment seen in patients who carry mutations in
the NEB gene25. At the mid-leg level muscle changes were more pronounced in lateral and
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medial gastrocnemius, peroneal group and soleus, with less prominent involvement of the
anterior tibialis. This is in contrast with the predominant involvement of the anterior tibialis
and soleus muscles in patients with nemaline myopathy caused by NEB mutations, and from
the relative sparing of the gastrocnemius seen in patients who carry ACTA 1 mutations25.
Analysis of muscle biopsies revealed striking similarities with phenomena described in the
Dutch and Australian-Dutch 15q-linked families 22,23. These consisted of frequent nemaline
bodies, prominent myofibrillar disorganization resulting in core-like formations, type I fiber
predominance and hypertrophy, and type II fiber atrophy. Decreased oxidative enzyme
activity in areas containing abundant rods occurs in various subtypes of nemaline myopathy
and therefore is not specific for NEM6 26. However, in addition to these pseudo-core lesions
we also found foci of complete myofibrillar dissolution appearing as aggregates of irregular
filamentous electron-dense material and having none or only a few small rod-like structures.
Similar abnormalities have been observed in the previously reported NEM6 families 22,23.
The combination of nemaline rods and core-like lesions has also been found in some
patients with nemaline myopathy due to ACTA1 gene mutations 27. However, it is
noteworthy that the pseudo-core and core-like lesions observed in NEM6 cases and some
nemaline myopathy patients who carry ACTA 1 mutations 27 differ from the classical
sharply demarcated cores observed in the central-core or core-rod disease associated with
RYR1 19,20 or NEB 21 mutations. Another unifying feature of the NEM6 variant is the
predominance and hypertrophy of type I vs. atrophic type II fibers. An abnormal fiber type I/
type II ratio is a frequent feature in nemaline myopathies, but most commonly this would be
type I fiber predominance and atrophy, not hypertrophy, 5,18,24, and only a minority of
characterized cases 18 show the pattern characteristic of the NEM6 patients.
Additional findings in the patients reported here was the presence of eosinophilic material in
some fibers, probably corresponding to areas of myofibrillary dissolution and massive rod
accumulation. This type of inclusion, is therefore different from the hyaline bodies observed
in myosin storage myopathy27. In addition to previous observations of α-actinin13,14 and
myotilin15 expression in rods, this study revealed filamin C immunofluorescence in rods,
thus expanding our knowledge regarding rod body composition.
Considering the phenotypic similarity to the previously reported NEM6 families, we
performed genotyping of 11 family members in the 15q21-q23 region by using some of the
same markers employed in the studies of the Dutch and Australian-Dutch families 23. The
disease-associated 15q haplotype perfectly co-segregates with the disease, suggesting that
nemaline myopathy in the Spanish family is allelic to the Dutch and Australian-Dutch
families. If we assume that the same unknown mutant gene causes nemaline myopathy in the
Spanish, Dutch and Australian-Dutch families, it must be located in a 7-megabase region
between markers D15S155 and D15S125 on chromosome 15q22.31, based on a
recombination previously identified in the Dutch and Australian-Dutch families 23. This
interval contains the fast α-tropomyosin (TPM1) gene that has not been implicated in
nemaline myopathy so far, but TPM1 mutations have been known to cause familial
hypertrophic cardiomyopathy type 3 29 and dilated cardiomyopathy 30. Analysis of the
TPM1 gene in the Dutch, Australian-Dutch and now Spanish patients has not identified any
causative changes. Eighteen other genes with known or unknown function have been
screened in patients in the Spanish family, but to-date no pathogenic mutations have been
found. The Spanish family is the third family genetically linked to the NEM6 chromosomal
region; further studies of these three families will help to identify the NEM6 gene.
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HE haematoxylin and eosin
MR magnetic resonance
MRC Medical Research Council
NADH nicotinamide adenine dinucleotide dehydrogenase
NEM nemaline myopathy
PCR polymerase chain reaction
SE spin echo
SDH succinic dehydrogenase
STIR short-time inversion recovery
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Pedigree of the Spanish nemaline myopathy family. Filled symbols indicate individuals
affected with myopathy; empty symbols represent unaffected family members. Bracketed
bars indicate disease-associated haplotype constructed with the use of chromosome 15q
marker alleles. The marker order, from centromere to telomere, is D15S1033, D15S1036,
D15S1507, D15S153. D15S131.
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Upper limb hypotrophy (A and B), particularly of forearm muscles, in contrast with
relatively preserved muscle bulk in lower limbs (C and D) in individual III:5.
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Magnetic resonance imaging of the lower extremities of patient II:3 showing diffuse fatty
replacement of thigh (A) and leg muscles (B), specially in the lateral and medial
gastrocnemius, peroneal group and soleus, with less prominent involvement of the anterior
tibialis. The same pattern of muscle involvement was observed on muscle CT scans in
patient II:5 (C, D). In the younger individual (III:5), minor abnormalities were observed (E,
F).
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Histochemical findings in individuals II:3 (A to C), and II:5 (D to J) of the Spanish
nemaline myopathy family. (A) Marked variation in the fiber size; abnormal multiple small
or confluent dark-green to red-purple inclusions in the cytoplasm. (B) Areas corresponding
to rods appear eosinophilic on H&E stain; some fibers contain hyaline material in areas
under the sarcolemma. (C) Rimmed vacuoles in an atrophic fiber (arrow). (D) Marked
variation in the fiber size and mildly increased connective tissue. Aggregates of typical
nemaline rods in multiple fibers; isolated ragged red fibers (arrow). (E) Clusters of rods in
areas under the sarcolemma and centrally within the cytoplasm. (F and G) In addition to
smaller rods, some fibers contain confluent red or purple inclusions. (H and I) Oxidative
stain reaction showing multiple core-like areas and ring fibers (arrow). (J) Double labeling
immunohistochemistry for slow (grey) and fast (brown) myosin demonstrating type I fiber
predominance and hypertrophy and type II fiber atrophy. Bar in A (A, D and H) = 100 μm;
Bar in B (B, C, E, F, G and I) = 50μm; Bar in J = 200 μm.
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Immunocytochemical analysis with fluorescein-conjugated monoclonal antibodies in muscle
biopsy from individual II: 5, showing prominent α-actinin (A), filamin C (B), and myotilin
(C) expression in rods and in some core-like areas. A ring fiber is visible in C (arrow). Bar
in A (A to C) = 50 μm.
Olivé et al. Page 14














Ultrastructural findings in patients II:3 and II:5 of the family. (A) Nemaline rods emanating
from the Z-disks and resulting in sarcomere disorganization in heavily affected cells. (B)
Aggregates of rod bodies located under the sarcolema or (C and D) between the myofibrils.
(C) Typical rods in a fiber with well preserved sarcomere structure. (E) Complete
dissolution of the myofibrils in a region occupied by electron dense filamentous material,
and (F) on higher magnification, destructive filamentous masses probably of Z-disk origin
containing only a few rod-like bodies.
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